Zibotentan

Generic Name: Zibotentan

Brand Names: -

Drug Type: Small Molecule

Chemical Formula: C_₁₉H_₁₆N_₆O_₄S

CAS Number: 186497-07-4

Unique Ingredient Identifier: 8054MM4902

Indication: Investigated for use/treatment in prostate cancer.

Associated Conditions: -

Associated Therapies: -

Clinical Trials

Liver Fibrosis Treatment Market 2034: EMA, PDMA, FDA Approvals, Clinical Trials, Therapies, Epidemiology, Medication, and Companies

The Liver Fibrosis market, valued at ~USD 2,308 million in 2023, is expected to grow significantly by 2034, driven by rising prevalence and new therapies. The US leads in market size and cases, with Germany leading in the EU. Key companies include Gilead Sciences, Pfizer, and AstraZeneca, focusing on emerging treatments like Efruxifermin and Aramchol.

Drug Development Updates

Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.

Home Terms & Conditions Privacy Policy